Indeed, parameters describing the influence of MMP-9 levels in transgenic mouse groups on neural excitability (latency time, spikes number) suggest that the size of the stroke, dependent on MMP-9 activity levels, may have an impact on epileptic parameters in the PTZ-threshold test. The gene discussed is MMP9; the disease is stroke disorder.